FDA Inspection 1089159 — Meribel Pharma Karlskoga AB
The FDA completed an inspection of Meribel Pharma Karlskoga AB on Mar 22, 2018 in Karlskoga. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 22, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Karlskoga (Sweden)
Additional details
Mutual Recognition Agreement (MRA)